RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:500163

Witteveen-Kolk syndrome

low confidenceDisorder

Also known as: SIN3A-related intellectual disability syndrome · WITKOS

Publications

6,329

Trials

0

Interventional, condition-specific

Researchers

1,493

Distinct authors in sample

Gene link

SIN3A

Definitive

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

A rare genetic neurodevelopmental syndrome characterized by mild , , facial features, growth- and feeding problems, , , behavioral problems and a variety of abnormalities.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.

  1. Gene identifiedPresent

    Definitive — SIN3A

  2. LiteraturePresent

    6,329 matched papers (3,895 in last 10 years) Source

  3. Phenotype characterisedPresent

    20 HPO annotations (e.g. Hearing impairment; Abnormality of the skeletal system; Compulsive behaviors) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (SIN3A).

GenCC classification: Definitive.

Phenotypes (Monarch / HPO)

20

Associated phenotypes · MONDO:0044699

  • Hearing impairment
  • Abnormality of the skeletal system
  • Compulsive behaviors
  • Short attention span
  • Fine hair

Showing 5 of 20 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

6,329

6,329 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

6,329 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

3,895 in the last 10 years · low confidence

Phrase hits: 987 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,493

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Zhang Y9 papers · 2026

    The Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.

    Papers in Europe PMC
  2. 02
    Witkoś J6 papers · 2026

    Faculty of Medicine and Health Science, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland. jwitkos@uafm.edu.pl.

    Papers in Europe PMC
  3. 03
    Sun Y5 papers · 2026

    State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, Dalian, Liaoning, China.

    Papers in Europe PMC
  4. 04
    Liu Y4 papers · 2026

    The Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.

    Papers in Europe PMC
  5. 05
    Błażejewski G3 papers · 2025

    Faculty of Medicine and Health Science, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland.

    Papers in Europe PMC
  6. 06
    Guo Z3 papers · 2025

    Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.

    Papers in Europe PMC
  7. 07
    Hartman-Petrycka M3 papers · 2026

    Department of Basic Biomedical Science, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Poland.

    Papers in Europe PMC
  8. 08
    Huang Y3 papers · 2026

    Department of Neurology, Nanfang Hospital.

    Papers in Europe PMC
  9. 09
    Kleefstra T3 papers · 2026

    Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, The Netherlands.

    Papers in Europe PMC
  10. 10
    Li X3 papers · 2025

    Neonatology Department, The Affiliated Hospital of Qingdao University, NO.16Jiangsu Road, Shinan district, Qingdao 266003, Shandong, China.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

low confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Witteveen-Kolk syndrome — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("Witteveen-Kolk syndrome" OR "SIN3A-related intellectual disability syndrome" OR "WITKOS") OR ("SIN3A" OR "SIN3A syndrome" OR "SIN3A-related")

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Witteveen-Kolk syndrome" OR "SIN3A-related intellectual disability syndrome" OR "WITKOS"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (6329) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity

Ingested 2026-07-27T17:41:56.524Z